PVI
TBIO

Pura Vida Investments’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Pura Vida Investments’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-31,794
Closed -$6.18M – 290
2021
Q4 		$6.18M Buy
31,794
+9,951
+46% +$1.55M 0.22% 102
2021
Q3 		$4.38M Sell
21,843
-379
-2% -$96.2K 0.13% 154
2021
Q2 		$8.8M Buy
+22,222
New +$7.86M 0.27% 83

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pura Vida Investments's TBIO Position: Q1 2022 in Review

Pura Vida Investments sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q1 2022, closing a stake of 31,794 shares — an estimated $6.18M sold.

Pura Vida Investments first reported a position in TBIO in Q2 2021 and held it in 3 quarters. The position peaked at $8.8M in Q2 2021. 47 funds tracked by Wall St. Rank hold TBIO as of Q1 2022.

  • Pura Vida Investments reported no remaining Telesis Bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Pura Vida Investments sold 31,794 Telesis Bio, Inc. Common Stock shares in Q1 2022, an estimated $6.18M.
  • Pura Vida Investments first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Pura Vida Investments's Telesis Bio, Inc. Common Stock position peaked at $8.8M in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q1 2022.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.